Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK, Pelttari LM, Kiiski JI, Khan S, Nurmikolu M, Suvanto M, Aho N, Tasmuth T, Kalso E, Schleutker J, Kallioniemi A, Heikkilä P; FinnGen; Aittomäki K, Blomqvist C, Nevanlinna H. Nurmi AK, et al. Among authors: khan s. Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Kiiski JI, Pelttari LM, Khan S, Freysteinsdottir ES, Reynisdottir I, Hart SN, Shimelis H, Vilske S, Kallioniemi A, Schleutker J, Leminen A, Bützow R, Blomqvist C, Barkardottir RB, Couch FJ, Aittomäki K, Nevanlinna H. Kiiski JI, et al. Among authors: khan s. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15172-7. doi: 10.1073/pnas.1407909111. Epub 2014 Oct 6. Proc Natl Acad Sci U S A. 2014. PMID: 25288723 Free PMC article.
Screening of HELQ in breast and ovarian cancer families.
Pelttari LM, Kinnunen L, Kiiski JI, Khan S, Blomqvist C, Aittomäki K, Nevanlinna H. Pelttari LM, et al. Among authors: khan s. Fam Cancer. 2016 Jan;15(1):19-23. doi: 10.1007/s10689-015-9838-4. Fam Cancer. 2016. PMID: 26351136
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
Kiiski JI, Fagerholm R, Tervasmäki A, Pelttari LM, Khan S, Jamshidi M, Mantere T, Pylkäs K, Bartek J, Bartkova J, Mannermaa A, Tengström M, Kosma VM, Winqvist R, Kallioniemi A, Aittomäki K, Blomqvist C, Nevanlinna H. Kiiski JI, et al. Among authors: khan s. Int J Cancer. 2016 Dec 15;139(12):2760-2770. doi: 10.1002/ijc.30394. Epub 2016 Sep 19. Int J Cancer. 2016. PMID: 27542569 Free PMC article.
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
Kiiski JI, Tervasmäki A, Pelttari LM, Khan S, Mantere T, Pylkäs K, Mannermaa A, Tengström M, Kvist A, Borg Å, Kosma VM, Kallioniemi A, Schleutker J, Bützow R, Blomqvist C, Aittomäki K, Winqvist R, Nevanlinna H. Kiiski JI, et al. Among authors: khan s. Breast Cancer Res Treat. 2017 Nov;166(1):217-226. doi: 10.1007/s10549-017-4388-0. Epub 2017 Jul 12. Breast Cancer Res Treat. 2017. PMID: 28702895 Free PMC article.
SNPs in lncRNA Regions and Breast Cancer Risk.
Suvanto M, Beesley J, Blomqvist C, Chenevix-Trench G, Khan S, Nevanlinna H. Suvanto M, et al. Among authors: khan s. Front Genet. 2020 Jun 30;11:550. doi: 10.3389/fgene.2020.00550. eCollection 2020. Front Genet. 2020. PMID: 32714364 Free PMC article.
Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Heikkinen T, Korpela T, Fagerholm R, Khan S, Aittomäki K, Heikkilä P, Blomqvist C, Carpén O, Nevanlinna H. Heikkinen T, et al. Among authors: khan s. Breast Cancer Res Treat. 2013 Aug;141(1):79-88. doi: 10.1007/s10549-013-2671-2. Epub 2013 Aug 24. Breast Cancer Res Treat. 2013. PMID: 23974830
17,888 results
You have reached the last available page of results. Please see the User Guide for more information.